CVS Health [CVS] gets an upgrade to a Buy from Jefferies
Jefferies took its CVS Health [CVS] rating to the equivalent of Buy from Hold, and the price target to $90.0, in a research note dated 2021-01-08. That figure represents around a 21.62% premium from where the company’s shares closed on Thursday. Some new analysts also started their coverage, with Piper Sandler’s analysts assigning the shares […]